Holen Sie sich die Stockscreener-App
1.29
6.52%
-0.09
Handel nachbörslich:
1.26
-0.03
-2.33%
Schlusskurs vom Vortag:
$1.38
Offen:
$1.39
24-Stunden-Volumen:
180.95K
Relative Volume:
2.07
Marktkapitalisierung:
$9.90M
Einnahmen:
$598.00K
Nettoeinkommen (Verlust:
$-44.93M
KGV:
-0.1552
EPS:
-8.31
Netto-Cashflow:
$-17.32M
1W Leistung:
+2.79%
1M Leistung:
-23.67%
6M Leistung:
-66.92%
1J Leistung:
-94.38%
1-Tages-Spanne:
$1.26
$1.3968
1-Wochen-Bereich:
$1.19
$1.57
52-Wochen-Spanne:
$1.19
$23.70
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Firmenname
Ernexa Therapeutics Inc
Sektor
Branche
Telefon
(617) 798-6700
Adresse
1035 CAMBRIDGE STREET, CAMBRIDGE
Vergleichen Sie ERNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.29 | 9.90M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten
What candlestick patterns are forming on Ernexa Therapeutics Inc.Inflation Watch & Weekly Momentum Stock Picks - newser.com
Combining machine learning predictions for Ernexa Therapeutics Inc.Weekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
How to manage a losing position in Ernexa Therapeutics Inc.Weekly Stock Recap & Weekly Stock Performance Updates - newser.com
Historical volatility pattern of Ernexa Therapeutics Inc. visualizedJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
News impact scoring models applied to Ernexa Therapeutics Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
How to build a dashboard for Ernexa Therapeutics Inc. stockMarket Sentiment Report & Real-Time Market Sentiment Alerts - newser.com
What’s next for Ernexa Therapeutics Inc. stock priceJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
Volatility clustering patterns for Ernexa Therapeutics Inc.Share Buyback & Real-Time Buy Signal Notifications - Newser
Can technical indicators confirm Ernexa Therapeutics Inc.’s reversal - Newser
Real time alert setup for Ernexa Therapeutics Inc. performance2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Is now a turning point for Ernexa Therapeutics Inc.July 2025 Analyst Calls & Scalable Portfolio Growth Ideas - Newser
Full technical analysis of Ernexa Therapeutics Inc. stockPrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Ernexa Therapeutics Inc. stock trend forecastQuarterly Trade Report & Daily Market Momentum Tracking - Newser
Does Ernexa Therapeutics Inc. show high probability of reboundDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Is Ernexa Therapeutics Inc. stock poised for growthJuly 2025 Catalysts & Advanced Technical Signal Analysis - Newser
Should you hold or exit Ernexa Therapeutics Inc. nowJuly 2025 Chart Watch & AI Forecasted Entry and Exit Points - Newser
Measuring Ernexa Therapeutics Inc.’s beta against major indices2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - Newser
How to interpret RSI for Ernexa Therapeutics Inc. stockQuarterly Portfolio Report & Low Risk Investment Opportunities - Newser
Published on: 2025-09-10 11:13:31 - Newser
Using fundamentals and technicals on Ernexa Therapeutics Inc.Earnings Recap Summary & Growth Focused Investment Plans - Newser
Ernexa Therapeutics reports 51% reduction in operating expenses - Investing.com
Ernexa Therapeutics reports 51% reduction in operating expenses By Investing.com - Investing.com Nigeria
Ernexa Therapeutics Reports Significant Operational Improvements and Financial Performance for H1 2025 - Quiver Quantitative
Ernexa Therapeutics provides update on operational excellence and performance - MarketScreener
Ernexa Therapeutics Provides Update on Operational Excellence and Performance - GlobeNewswire
51% Cost Reduction: How Ernexa Therapeutics Cut $5.5M in Losses While Advancing Cancer Cell Therapies - Stock Titan
Detecting price anomalies in Ernexa Therapeutics Inc. with AIJuly 2025 Rallies & Long-Term Investment Growth Plans - Newser
Volume spikes in Ernexa Therapeutics Inc. stock – what they meanQuarterly Trade Summary & Growth Focused Entry Point Reports - Newser
How institutional ownership impacts Ernexa Therapeutics Inc. stockJuly 2025 Breakouts & Consistent Profit Focused Trading Strategies - Newser
Is Ernexa Therapeutics Inc. showing signs of accumulationAnalyst Downgrade & Stock Portfolio Risk Control - Newser
Price action breakdown for Ernexa Therapeutics Inc.2025 Market Trends & Detailed Earnings Play Strategies - Newser
real time alert setup for ernexa therapeutics inc. performance2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Published on: 2025-09-09 05:17:04 - Newser
Using data tools to time your Ernexa Therapeutics Inc. exitQuarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Developing predictive dashboards with Ernexa Therapeutics Inc. dataJuly 2025 Rallies & Stepwise Trade Signal Implementation - Newser
What’s the recovery path for long term holders of Ernexa Therapeutics Inc.CEO Change & Long-Term Capital Growth Strategies - Newser
Head to Head Survey: Harrow (NASDAQ:HROW) versus Ernexa Therapeutics (NASDAQ:ERNA) - Defense World
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):